Blood modifications associated with end stage renal disease duration, progression and cardiovascular mortality: a 3-year follow-up pilot study.
about
Red blood cell abnormalities and the pathogenesis of anemia in end-stage renal disease.Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease.
P2860
Blood modifications associated with end stage renal disease duration, progression and cardiovascular mortality: a 3-year follow-up pilot study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Blood modifications associated ...... 3-year follow-up pilot study.
@ast
Blood modifications associated ...... 3-year follow-up pilot study.
@en
type
label
Blood modifications associated ...... 3-year follow-up pilot study.
@ast
Blood modifications associated ...... 3-year follow-up pilot study.
@en
prefLabel
Blood modifications associated ...... 3-year follow-up pilot study.
@ast
Blood modifications associated ...... 3-year follow-up pilot study.
@en
P2093
P50
P1476
Blood modifications associated ...... 3-year follow-up pilot study.
@en
P2093
Apostolos C Kokkalis
Hara T Georgatzakou
Issidora S Papassideri
Vasillis L Tzounakas
P304
P356
10.1016/J.JPROT.2014.02.009
P577
2014-02-15T00:00:00Z